Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Vitamin-based therapy for cancer: 1α,25-dihydroxyvitamin D(3) suppresses the expression of cell cycle regulatory protein CCNA2 via up regulation of its target gene, 21/January/20145, 12.14 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests that 1α,25-dihydroxyvitamin D(3), by increasing the expression of its target gene, it may suppress the expression of Cyclin A2 and inhibit the proliferation of cells. Thereby, it may promote tumor suppression. Thus, pharmacological formulations encompassing “1α,25-dihydroxyvitamin D(3) or its analogues” may be used to inhibit the progression of human tumors.
Amount: $ 300
Undisclosed information: How 1α,25-dihydroxyvitamin D(3) suppresses the expression of Cyclin A2
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
